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ABSTRACT: Patient reported outcome measures (PROMs) are key tools when performing clinical research and PROM data are
increasingly used to inform clinical decision-making, patient-centered care, health policy and more recently, reimbursement decisions.
PROMs must possess particular properties before they are used. Thus purpose of this paper is to give an overview of PROMs, their
definition, how their evidence can be assessed, how they should be reported in clinical research, how to choose PROMs, the types of
PROMs available in orthopaedics, where these measures can be found, PROMs in orthopaedic clinical practice and what are some key
next steps in this field. If PROMs are used in accordance with the guidance in this article, I believe we will gain considerable insight
into PROMs in orthopaedics and will advance this field in a way that can contribute to science, improve patient care and save
considerable resources.  2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:2098–2108, 2017.
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Why Patient Reported Outcome Measures?
The development, testing, and implementation of tools
to aid in the measurement of phenomena in medicine
are central to clinical practice and clinical research.
Measurements in clinical practice form the basis of
diagnosis, prognosis, evaluation and follow-up. Meas-
urements in clinical research allow for the collection of
data that afford us the information needed to test
specific hypotheses.1 The field of measurement
in medicine includes both psychometrics and
clinimetrics.2–4 But, it has been argued that there is
little distinction between these two areas.3 Throughout
this paper the term psychometrics will be used and
more generally the term measurement to refer to these
fields.
There are many types of measurements used in
medicine including subjective (e.g., patient, clinician
reported) and objective (e.g., imaging or laboratory
tests) types of measures. Patient reported outcome
measures (PROMs), also called self-report measures,
propose to collect information related to constructs
that are reported by the patients themselves, without
interpretation by other parties.1 Patient reported out-
comes include perceptions and opinions on symptoms,
functioning, health–related quality of life (HRQoL),
and satisfaction, among other areas (Fig. 1).1,5 PROMs
different focuses including: Generic health-related
(e.g., Medical Outcomes Survey Short Form-36), dis-
ease/diagnosis specific (e.g., Western Ontario Rotator
Cuff Index), or regionally specific, for example,
American Shoulder and Elbow Society score).
Patient reported outcome measures (PROMs) are
key tools when performing clinical research and
PROM data are increasingly used to inform clinical
decision-making, patient-centered care, health policy
and more recently, reimbursement decisions
(Fig. 2).6–8 Furthermore, substantial federal fiscal
commitment has been directed at developing PROMs
[e.g., Patient Reported Outcome Measurement Infor-
mation System (PROMIS)].9–17 Evidence suggests that
the use of PROMs has increased dramatically over the
last 20 years and it has been noted that this trend will
continue.18 Therefore, the use of PROMs must be
tempered and directed by solid evidence and appropri-
ate guidance.
Quality Assessment of Patient Reported Outcome
Measures
Health status measurement instruments must possess
adequate measurement properties (e.g., reliability,
validity, responsiveness) to be useful for research or
patient care.2,21–23 A measurement tool is considered
to be valid when it actually measures what it proposes
to measure. There are several types of validity includ-
ing: Content, construct, and criterion validity. Reliabil-
ity is the property of measuring some phenomenon in
a predictable manner (repeatability). Some forms of
reliability include: Internal consistency, test-retest or
intra-rater, and inter-rater reliability. Finally, respon-
siveness is the ability to detect change in the underly-
ing construct over time, even if the changes are
small.21–23 Table 1 describes definitions of all measure-
ment properties.
Outcomes used in patient centered outcomes re-
search, such as PROMs, should be of high quality so
as to ensure that these measures do not introduce bias
in the effect estimates for these outcomes. For exam-
ple, poor quality PROMs used in effectiveness studies
will lead to unreliable and misleading results of these
studies, potentially resulting in harm to the patient or
the inappropriate use of resources (e.g., health care
dollars, research funding allocation). PROMs must
have appropriate measurement properties (see Table 1)
to detect small but relevant treatment effects or
changes in individual and groups of patients. Only
then can we trust the results of research that includes
such PROMs to inform decision-making.
To properly evaluate the quality of psychometric
properties of a PROM one should first search for or
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conduct a systematic review of existing evidence, and
then secondarily initiate new primary research to
focus on areas where the measure is either flawed or
where no evidence is available. Searching for PROMs
involves a careful use of available electronic databases
including general databases such as MEDLINE,
Cochrane Library, and EMBASE as well as topic
specific databases such as SportDiscus and online
warehouses of such systematic reviews such as the
COSMIN database of systematic reviews of measure-
ment instruments (http://database.cosmin.nl/). For
conducting new systematic reviews of evidence for
specific PROMs, there have been several methods
proposed for evaluating the properties of a PROM.24–26
The most widely used and recent set of criteria for
assessing the measurement properties of PROMs is
the COnsensus-based Standards for the selection of
health status Measurement INstruments (COSMIN)
which include detailed sets of items for assessing the
methodological quality of research that tests a psycho-
metric quality.25 The COSMIN checklist includes sets
of items for assessing a study’s methodological quality
that proposes to assess one of nine measurement
properties (i.e., internal consistency, reliability, mea-
surement error, content validity, structural validity,
hypothesis testing, cross-cultural validity, criterion
validity, and responsiveness) as well as two additional
boxes to extract information regarding interpretability
Figure 1. PROMs and decision making.19
Figure 2. Settings for PROM collection and use.20
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and generalizability, which strictly are not called
measurement properties, and finally one box to assess
item response theory (IRT) methods if used.25,26 Each
of the nine measurement properties include a selection
of items that are scored on a 4 point Likert scale of
methodological quality as excellent, good, fair, poor
quality.27,28 The COSMIN checklist is the most com-
prehensive checklist available, was developed using
strong methods and is widely used.25,26
When performing systematic reviews of the psycho-
metric evidence of PROMs one must be careful to
assess both the methodological quality of each the
primary studies and also assess the evidence for or
against the psychometric property itself.1,29–31 For
example, if a published study investigates the inter-
rater reliability of an instrument, that study must
have appropriate methods of doing so (e.g., a proper
sample size calculation for the reliability statistic) and
also the level of the reliability statistic must meet
some cut-off (e.g, intraclass correlation coefficient/
weighted k0.70 OR Pearson’s r0.80). A compre-
hensive set of criteria for assessing the psychometric
evidence of health status measurement instruments
were proposed by Terwee et al.22 (see Table 1).29,32
Each criterion is rated as positive (þ), indeterminate
(?; unclear from what is reported), or negative (). If
no information for a property is available in the
literature, a rating of zero (0) would be given to
indicate no evidence.
Finally, the methodological quality of the included
studies and the psychometric evidence should be
synthesized to arrive at an overall rating. Schellin-
gerhout et al.32 proposed a synthesis method which
combines the consistency of the psychometric evidence
with the methodological quality of the included studies
and the level of evidence proposed by the Cochrane
Back Review Group.33 The overall results are then
categorized as positive (þ), unknown/indeterminate
(?), negative (), or no evidence (0) accompanied with
the overall level of evidence ranging from unknown to
strong (see Table 2). A rating of conflicting results
(/þ) is given when the number of positive ratings
equals the number of negative ratings. Using this
method, when combined across studies, the levels of
evidence are: Strong (representing consistent findings
in multiple studies of good methodological quality OR
in one study of excellent methodological quality),
moderate (representing consistent findings in multiple
studies of fair methodological quality OR in one study
of good methodological quality), limited (representing
one study of fair methodological quality), conflicting
(representing conflicting findings), and unknown (rep-
resenting the existence of only studies of poor method-
ological quality).
Choosing a PROM
Thus when attempting to choose a PROM for use
clinically or research in orthopaedics, and any other
area, one must be careful to identify an appropriate
instrument for their specific purposes (e.g., condition/
disease/diagnosis specific PROM, regionally specific
PROM, generic health/QOL PROM) and then must
collect evidence for the quality of that instrument.
Just because an instrument is used frequently in the
published literature does not guarantee its quality. In
fact, there is extensive evidence, which we review
below, that PROMs used in many areas of orthopae-
dics are significantly flawed, or at least, lack data on
their psychometric properties (e.g., Refs.29–31). The use
of poor quality instruments will result in biased or
unreliable effect estimates and can potentially mislead
decision makers relying this evidence as well as harm
patients and waste resources.
There is some empirical evidence that clinical trials
which use poor or unknown quality PROMs are more
likely to report that a treatment was superior to
control, by up to 89% (RR 1.89, 95%CI 1.40–2.56), and
the effect was even greater in non-pharmacologic
trials, 168% (RR 2.68, 95%CI 1.86–3.84) (e.g., Ref.34).
Furthermore, clinical trials that include PROMs fre-
quently do not report any information on the mea-
sure’s psychometric properties (e.g., Ref.35).
The issue of underreporting is a problem in many
sections of published clinical trials and has spurred
on much literature in the form of reporting guide-
lines and recommendations aimed at improving the
completeness of published scientific reports and pro-
tocols (http://www.equator-network.org/library/). In
particular, an extension of the Consolidated Stand-
ards of Reporting Trials (CONSORT) for patient
reported outcomes (PRO) was developed to guide the
reporting of PROs in randomized clinical trials
Table 2. Levels of Evidence for the Overall Quality of the Measurement Property30
Level Rating Criteria
Strong þþþ or  Consistent findings in multiple studies of good methodological
quality OR in one study of excellent methodological quality
Moderate þþ or  Consistent findings in multiple studies of fair methodological
quality OR in one study of good methodological quality
Limited þ or  One study of fair methodological quality
Conflicting þ/ Conflicting findings
Unknown ? Only studies of poor methodological quality
30, Reference number, þ, positive result, , negative result.
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(RCTs; CONSORT-PRO).36 The CONSORT-PRO
checklist contains five items to refer to when report-
ing the use of a PRO as a primary and secondary
outcome measure. Related to this effort, a task force
of the International Society of Quality of Life
(ISOQOL) Research created a suite of reporting
standards for HRQOL outcomes in RCTs.37 Further-
more, ISOQOL developed a set of minimum stand-
ards for the design and selection of PROMs for use in
patient-centered outcomes research (PCOR) and com-
parative effectiveness research (CER).38 These can be
used in conjunction with COSMIN criteria when
choosing a PROM for use in research. In some cases,
the evidence for a PROMs properties may not exist,
but this should not prevent us from doing research.
In addition, guidance for the reporting of PROs in
clinical trial protocols is currently under construc-
tion.39 These standards should be adhered to when
choosing a PRO for clinical research and when
reporting that research in the form of peer-reviewed
manuscripts.
PROMs in Clinical Research
The process of selecting a PROM for patient monitor-
ing or clinical research must be considered carefully.
There is empirical evidence that choosing an instru-
ment on the basis of frequency of use in the literature
does not guarantee its quality. For example, in a
systematic review of PROMs used in clinical publica-
tions of patient’s following knee arthroplasty, the
Knee Society Score (KSS), and the Western Ontario
McMaster Osteoarthritis Index (WOMAC) were used
in over 80% of the 438 included articles.40 But a
recently published rigorous systematic review of
PROMs developed and tested in patients undergoing
or who have undergone total knee arthroplasty found
that the KSS and WOMAC exhibited less than favor-
able psychometric properties.30 This suggests there is
a large volume of published clinical research that use
non-valid, unreliable and unresponsive instruments to
measure patient reported outcomes, and therefore any
such findings are not trustworthy. Of course, this is
just one example (i.e., knee arthropalsty) from the
literature and additional rigorous work exploring this
hypothesis is needed.41
With that caution in mind, when choosing a
PROM for clinical research or monitoring of patients
in clinical practice you need to determine what
domains or constructs you want to measure (e.g.,
pain, physical function, quality of life), what types of
patients you plan to include (e.g., patients who have
undergone total hip replacements or have a specific
diagnosis), if an outcome measure exists that cap-
tures these domains for these patients, what the
psychometric evidence is for the measure or mea-
sures you have identified, and finally if the test is
usable (i.e., what is the test burden, time it takes to
complete and are the scores sensible and interpret-
able). This is not a trivial process obviously as each
of these steps will take time and concerted effort.
The ISOQOL standards (see Table 3) should be
referred to when choosing a PROM for research and
can also be used as a guide for the choice of PROMs
in clinical practice39 Furthermore, below we describe
how to assess and use systematic reviews of the
psychometric properties of instruments.
Core Outcome Measurement Sets
Furthermore, one should also consider looking for a
core outcome set (COS) in the area of research they
planning. A COS is defined as an agreed upon
minimum selection of outcomes that should be mea-
sured and reported in all clinical trials for a particu-
lar health condition.42 There is an expectation that
the core set of outcomes would always be collected
and reported, but it would not preclude use of
additional outcomes in particular clinical research. It
is argued that the lack of uniformity in outcome
measurement across trials limits our ability to com-
pare findings between studies or to pool data for
meta-analyses. Also, selective outcome reporting (i.e.,
selective reporting of favorable or statistically signifi-
cant outcomes) can bias the results of systematic
reviews.43 Thus, in an effort to reduce heterogeneity
in outcomes measured across clinical trials, the
development of core COS in specific health conditions
has been recommended.44 A COS would increase the
use of important outcomes (i.e., important to all
relevant stakeholders; e.g., patients, clinicians,
researchers), outcomes with sufficient psychometric
evidence for their use, improve the validity of
outcome data for these outcomes in clinical research
and increase the feasibility of conducting meta-
analyses on such topics.42,45
The Core Outcome Measures in Effectiveness Trials
(COMET)42 and the Outcome Measures in Rheumatol-
ogy (OMERACT)46 initiatives provide methodological
guidance, including a stepwise approach, for the
development of a COS.46–48 Several examples of COSs
that have been developed for orthopaedic conditions
and procedures include: Degenerative lumbar condi-
tions,49 non-specific low back pain,50 post-surgical
knee pain,51 hip fractures,52 shoulder pain,53,54 and
distal radius fractures.55 There are many additional
areas where COSs are needed in orthopaedics. Of
course, a frequent component of a COS is a PROM,
thus when planning on conducting a clinical trial and
seeking a PROM it is wise to search for a COS in your
area of inquiry. The COMET group houses a database
of COSs on their website.
Furthermore, beyond disease (e.g., rotator cuff tear)
or regionally specific (e.g., shoulder) PROMs one might
consider other more general PROMs such as those
that measure overall HRQOL (e.g., EuroQol EQ-5D)
since these measures may give some determination of
the overall impact of the condition of the person’s
quality of life. This might allow a comparison between
conditions as to their overall impact on individuals.56
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There are many instruments available, many
PROMs, that can be used in most areas of orthopae-
dics (e.g., Refs.29–31,49–55). But, if an appropriate
PROM does note exist, after an exhaustive literature
search for said instrument, then one may embark on
developing a new instrument specific to their needs.
When developing a new instrument it is imperative
that proper methods be followed. It is not within the
scope of this paper to describe these, but many
excellent textbooks are available to help those that are
interested (e.g., Refs.1,2,5,57–58).
Systematic Reviews of Psychometric Evidence for PROMs
in Orthopaedics
There has been some progress made in systematically
evaluating the psychometric properties of a patient
reported outcome measure for use in orthopaedics.
Here I list some of the systematic reviews in this area
that use relatively accepted methods. But this is not a
comprehensive systematic look at all the evidence of
PROMs in orthopaedics. As noted above, searching for
PROMs involves a careful use of available electronic
databases including general databases such as MED-
LINE, Cochrane Library, and EMBASE as well as
topic specific databases such as SportDiscus and online
warehouses of such systematic reviews such as the
COSMIN database of systematic reviews of measure-
ment instruments (http://database.cosmin.nl/).
Although this is not a comprehensive list, system-
atic reviews of the psychometric evidence for PROMs
for use in orthopaedic related conditions have been
completed for the knee,59 total knee replacement,30
anterior cruciate ligament injuries,60 total hip replace-
ment,61 foot and ankle disorders,31,62 chronic ankle
instability,63 rotator cuff disease,29 shoulder disabil-
ity,64,65 shoulder specific PROMs,66 shoulder func-
tional scores,67 functional limitations in the athletic
shoulder,68 shoulder disability measures translated in
Portuguese,69 brachial plexus injuries,70 upper extrem-
ity following trauma,71 elbow,72 hand injuries,73,74
carpal tunnel syndrome,75 wrist and hand function,76
wrist,77 neck pain,78,79 non-specific neck pain,80 cervi-
cal degenerative disease,81 cervical pain, or dysfunc-
tion,82 neck-specific questionnaires in other
languages,83 non-specific low back pain.84,85 But many
more such systematic reviews are available for the
array of conditions that are seen by orthopaedic
surgeons.
Table 3. ISOQOL Minimum Standards for Patient-Reported Outcome (PRO) Measures Used in Patient-Centered
Outcomes Research or Comparative Effectiveness Research39
1 Conceptual and measurement model-A PRO measure should have documentation defining and describing the
concept(s) included and the intended population(s) for use. In addition, there should be documentation of how the
concept(s) are organized into a measurement model, including evidence for the dimensionality of the measure, how
items relate to each measured concept, and the relationship among concepts included in the PRO measure.
2 Reliability-The reliability of a PRO measure should preferably be at or above 0.70 for group-level comparisons, but
may be lower if appropriately justified. Reliability can be estimated using a variety of methods including internal
consistency reliability, test–retest reliability, or item response theory. Each method should be justified.
3 Validity
3a Content validity-A PRO measure should have evidence supporting its content validity, including evidence that
patients and experts consider the content of the PRO measure relevant and comprehensive for the concept,
population, and aim of the measurement application. This includes documentation of as follows: (1) qualitative and/
or quantitative methods used to solicit and confirm attributes (i.e., concepts measured by the items) of the PRO
relevant to the measurement application; (2) the characteristics of participants included in the evaluation (e.g.,
race/ethnicity, culture, age, gender, socio-economic status, literacy level) with an emphasis on similarities or
differences with respect to the target population; and (3) justification for the recall period for the measurement
application.
3b Construct validity-A PRO measure should have evidence supporting its construct validity, including documentation of
empirical findings that support predefined hypotheses on the expected associations among measures similar or
dissimilar to the measured PRO.
3c Responsiveness-A PRO measure for use in longitudinal research study should have evidence of responsiveness,
including empirical evidence of changes in scores consistent with predefined hypotheses regarding changes in the
measured PRO in the target population for the research application.
4 Interpretability of scores-A PRO measure should have documentation to support interpretation of scores, including
what low and high scores represent for the measured concept.
5 Translation of the PRO measure-A PRO measure translated to one or more languages should have documentation of
the methods used to translate and evaluate the PRO measure in each language. Studies should at least include
evidence from qualitative methods (e.g., cognitive testing) to evaluate the translations.
6 Patient and investigator Burden-A PRO measure must not be overly burdensome for patients or investigators. The
length of the PRO measure should be considered in the context of other PRO measures included in the assessment,
the frequency of PRO data collection, and the characteristics of the study population. The literacy demand of the
items in the PRO measure should usually be at a 6th grade education level or lower (i.e., 12 year old or lower);
however, it should be appropriately justified for the context of the proposed application.
PATIENT REPORTED OUTCOMES 2103
JOURNAL OF ORTHOPAEDIC RESEARCH OCTOBER 2017
When reading such systematic reviews, be careful
to be critical of the methods used in them to evaluate
the instruments. A systematic review of a sample of
148 reviews found that a very small proportion of
them, 7.4%, used proper methods for evaluating the
psychometric evidence.86 While this review is a bit
dated (2009), and given that the COSMIN and Evalu-
ating the Measurement of Patient Reported Outcomes
(EMPRO) guidance were published after this, I would
expect that more recent reviews of psychometric
properties of PROMs have better quality, but we
recommend that this hypothesis be explored. In the
end, make sure to use some explicit criteria when
assessing systematic reviews of the psychometric evi-
dence for PROMs. Effort should be made to rigorously
develop critical appraisal criteria for systematic
reviews of measurement properties of PROMs.
I provide some preliminary guidance in Table 4.
PROMs in Orthopaedic Clinical Practice
The use of PROMs across large samples can lead to
broad sweeping quality improvement initiatives, but
the use of PROMs on a patient by patient basis, to
inform clinical decision making during patient follow-
up, has its unique challenges. PROMs have been used
in clinical practice for many decades, whether it be a
pain scale or some more elaborate measure such as a
depression index. In orthopaedic surgery there is an
array of PROMs that could potentially be used to
manage individual patient care, some of which are
cited above,31–39,60–85 but many more exist and may be
appropriate for a specific clinical focus. The two most
comprehensive databases of individual PROMs are
PROQOLID87 and BIBLIOPRO,88 the latter of which
is a database of instruments in Spanish. Also, there is
an array of instruments offered through the PROMIS
initiative, which I describe in more detail here.
Table 4. Criteria to Consider When Evaluating a Systematic Review of Measurement Properties of a PROMa
Criteria Description
Question Was the question clearly articulated and understandable? [i.e., was the specific
subject matter area to which the PROMs apply (e.g., rotator cuff disease)
clear from the question]
Search Strategy Was the search strategy completely described and appropriate? Is it unlikely that the
search methods could have resulted in missed primary studies? (i.e., were
appropriate databases and search terms used, was there an attempt to hand
search or review reference lists and contact experts in the area to identify
additional studies)
Article Selection Were there explicit and appropriate criteria for inclusion and exclusion of the primary
studies (did these follow directly from the question posed)? Were there two
individuals who separately and independently performed the article selection?
Was agreement reported and was it sufficient? Were the number of articles
excluded at each stage and were the reasons for exclusion reported
(i.e. was the exclusion biased in any way)?
Data Extraction Were there two individuals who separately and independently performed the data
extraction? Was there training to do so appropriate? Was agreement reported and
was it sufficient?
Methodological Quality/Risk of
Bias Assessment
Were explicit criteria reported and used to assess the methodological quality
of the included studies? Were the criteria appropriate for the measurement
property(ies) assessed (e.g., COSMIN criteria)?23,27–28
Measurement Property
Assessment
Were explicit criteria reported and used to assess the measurement properties of the
included studies? Were the criteria appropriate for the measurement property(ies)
assessed?22
Synthesis Methods Were explicit criteria reported and used to synthesize the methodological quality and
the measurement properties of the included studies? Were the criteria appropriate
(e.g., Refs.30–32)?
Heterogeneity Did the authors account for differences between the primary studies evaluating the
same instruments (e.g., study setting, sample characteristics, study methods)?
Publication Bias Did the authors attempt to assess publication bias using funnel plots where applicable
(e.g., for quantitative criteria)?
Other Were other possible sources of bias in the systematic review avoided? (e.g., funding
biasb, investigator biasc)
aIf the answer is “no” to any of these questions, the methods of the review are flawed which could bias the results. The degree that
risks to bias actually influence the results is determine by a rationale assessment of overall study methods and results.
bFunding bias may result from a funding body supporting the systematic review whom also own the copyright or intellectual property
of some PROM under review.
cInvestigator bias may arise from authors of the systematic review also being authors of included primary studies or creators of the
included PROM(s).
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PROMIS is an NIH Common Fund project involving
the dynamic assessment of PROs. PROMIS includes
item banks that measure key health symptoms/con-
cepts for both the general population and several
chronic conditions. PROMIS item banks assess physi-
cal (physical function, fatigue, sleep disturbance, sleep
related impairment, pain behavior, and pain interfer-
ence), emotional (depression, anxiety, and anger),
cognitive (applied cognition-abilities and applied cogni-
tion general concerns), and social health (ability to
participate, satisfaction with social roles and activities,
emotional support, instrumental support, informa-
tional support, and social isolation). These item banks
were developed following rigorous protocols that in-
volved extensive formative research and statistical
analysis9–14; state-of the art psychometric analysis
was used to develop these measures (including classi-
cal test theory approaches and item response theory;
IRT). Items can be administered as a full set, a
computerized adaptive test (CAT), or a calibrated
“short form” (preselected set of items). An item bank
that can be administered as a CAT provides an
advantage to any preselected set of items (i.e., short
form) in maximizing assessment sensitivity while
simultaneously minimizing the number of items.
PROMIS is available, free of charge, through
www.assessmentcenter.net. PROMIS health assess-
ment data can be collected with minimal respondent
burden and without error introduced by data entry
through the use of electronic systems.89 While more
research needs to be done on the measurement proper-
ties of PROMIS instruments in orthopaedic samples, if
a clinician can manage to set up electronic data
collection then using a PROMIS instrument is cer-
tainly recommended.
How PROMs Contribute to Clinical Monitoring
But, as Porter et al.90 point out in their excellent
paper on the framework and guidance for implement-
ing patient-reported outcome in clinical practice, there
are many more potential clinical applications. Some of
these include: Supporting decision-making in the
diagnostic process (e.g., Screening, Diagnosis), inform-
ing risk stratification and prognosis (identification of
vulnerable patients and patients “at risk”), supporting
prioritization and goal setting, supporting decision-
making in indication for treatment (medical/surgical),
facilitating monitoring of general health status, health
status related to the specific diagnosis/risk, response
to treatment/management, facilitating communication
between patients and health professionals and within
teams and between professionals (i.e., consistent use of
PROMs along the entire care pathway).90
Challenges of Using PROMs in Clinical Practice
There are many challenges confronting the routine
use of PROMs in clinical practice.90,91 For example,
clinicians might view the addition of PROMs to
clinical practice disruptive or burdensome and clini-
cians may not envision how to use PROMs in their
practice or may lack the expertise to interpret and
apply the scores of information derived from such
measures.92–94 Therefore, training programs for clini-
cians in these areas are needed. Furthermore, many
question the efficacy or impact that feedback from
PROMs can have patient care and outcomes. In fact,
the evidence for the impact of using PROMs in
clinical practice is scarce. While several systematic
reviews have explored this area,95–108 most have
been reported to be inconclusive and this is mostly
due to methodologic flaws of the primary studies.90
That is, more research is needed, especially in
orthopaedics where there are virtually no rigorous
studies exploring these questions.
Where to go From Here?
Then where does all of this leave us in relation to
how we might find, use and improve PROMs in
clinical research and practice? I have chosen to frame
this last section in the form of what I view are the
most important needs facing the use of PROM in
clinical research and practice in orthpaedics: (i) The
systematic organization of the field of measurement
in orthopaedics to highlight the best PROMs, this
would involve performing rigorous systematic reviews
of the existing evidence and new psychometric re-
search on existing instruments. Also, there should be
no new development of PROMs unless an obvious
gap has been identified through a systematic review;
(ii) The creation of core outcome measurement sets in
all areas of orthopaedics to help guide clinical
researchers. The creation of core outcome sets must
proceed through a rigorous approach and be endorsed
by relevant research groups (e.g., OMERACT,
COMET) and clinical organizations (e.g, AOSSM,
etc); (iii) Rigorous research to determine how PROMs
are, or are not, useful to clinical management. For
example, we require much research to be be done to
determine how clinicians can use PROMs when
monitoring patients, and what are the most efficient
and effective methods to implement them in clinical
practice. Also, empirical evidence must be generated
on how the use of PROMs may help with care
decisions and how to present PROM data in elec-
tronic charts; (iv) Increased funding for research in
all of these areas. It is obvious that the disorganiza-
tion of this area of inquiry in orthopaedics obviates
the need for systematic and rigorous research that
should be supported federally and through other
funding bodies (e.g., foundations). Some funding
should go to supporting individual research projects
but also to supporting researchers themselves to gain
new experience in this area; and (v) Training pro-
grams for those interested in advancing research in
PROMs and for clinicians seeking to understand
their use and training at the resident or graduate
student level. Formal training programs and course
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will support clinicians and researchers in gaining
key knowledge to allow them to further implement
and refine PROMs and the related methodologic
research that is needed.
CONCLUSIONS
PROMs have an obvious place in othropaedics in that
they reflect underlying constructs of direct importance
to and as reported by patients themselves. These
measures are a key component to clinical research in
orthopaedics and may also be so for clinical practice in
orthopaedic surgery. If some of the needs can be
addressed as expressed above, I believe we will gain
considerable insight into PROMs in orthopaedics and
will advance this field in a way that can contribute to
science, improve patient care and save considerable
resources.
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